Vtv Therapeutics Stock Current Asset
| VTVT Stock | USD 24.98 0.54 2.21% |
vTv Therapeutics fundamentals help investors to digest information that contributes to VTv Therapeutics' financial success or failures. It also enables traders to predict the movement of VTv Stock. The fundamental analysis module provides a way to measure VTv Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VTv Therapeutics stock.
At this time, VTv Therapeutics' Other Current Assets are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 16.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 342.9 K in 2024. VTv | Current Asset |
vTv Therapeutics Company Current Asset Analysis
VTv Therapeutics' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current VTv Therapeutics Current Asset | 52.12 M |
Most of VTv Therapeutics' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, vTv Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
VTv Current Asset Historical Pattern
Today, most investors in VTv Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various VTv Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of VTv Therapeutics current asset as a starting point in their analysis.
VTv Therapeutics Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
VTv Total Assets
Total Assets |
|
In accordance with the recently published financial statements, vTv Therapeutics has a Current Asset of 52.12 M. This is 97.58% lower than that of the Biotechnology sector and 95.09% lower than that of the Health Care industry. The current asset for all United States stocks is 99.44% higher than that of the company.
VTv Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VTv Therapeutics' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VTv Therapeutics could also be used in its relative valuation, which is a method of valuing VTv Therapeutics by comparing valuation metrics of similar companies.VTv Therapeutics is currently under evaluation in current asset category among related companies.
VTv Fundamentals
| Return On Equity | -49.78 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 56.6 M | ||||
| Shares Outstanding | 2.43 M | ||||
| Shares Owned By Insiders | 54.68 % | ||||
| Shares Owned By Institutions | 16.05 % | ||||
| Number Of Shares Shorted | 32.24 K | ||||
| Price To Earning | (4.19) X | ||||
| Price To Sales | 3,631 X | ||||
| Revenue | 9 K | ||||
| Gross Profit | (9.93 M) | ||||
| EBITDA | (25.41 M) | ||||
| Net Income | (20.25 M) | ||||
| Cash And Equivalents | 17.95 M | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 529 K | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 3.12 X | ||||
| Book Value Per Share | (11.84) X | ||||
| Cash Flow From Operations | (18.52 M) | ||||
| Short Ratio | 0.18 X | ||||
| Earnings Per Share | (9.71) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 59.45 M | ||||
| Total Asset | 11.02 M | ||||
| Retained Earnings | (281.04 M) | ||||
| Working Capital | 38 K | ||||
| Current Asset | 52.12 M | ||||
| Current Liabilities | 10.58 M | ||||
| Net Asset | 11.02 M |
About VTv Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze vTv Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VTv Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of vTv Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:Check out VTv Therapeutics Piotroski F Score and VTv Therapeutics Altman Z Score analysis. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.